Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma
Open Access
- 4 April 2011
- journal article
- Published by Wiley in Histopathology
- Vol. 58 (5), 679-692
- https://doi.org/10.1111/j.1365-2559.2011.03821.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal CancerJNCI Journal of the National Cancer Institute, 2009
- Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Sporadic and Syndromic Hyperplastic Polyps and Serrated Adenomas of the Colon: Classification, Molecular Genetics, Natural History, and Clinical ManagementGastroenterology Clinics of North America, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Hyperplastic and Serrated Polyps of the ColorectumGastroenterology Clinics of North America, 2007
- Distinctive clinicopathological features ofKi-ras mutated colorectal cancersJournal of Surgical Oncology, 2006
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Mutations of the BRAF gene in human cancerNature, 2002
- Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colonCarcinogenesis: Integrative Cancer Research, 1995
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988